Posted inTechnology News TiumBio to transfer rare disease drug technologies to improve global health Posted by 6 September 2021 SK Chemicals developed the original substance of the drug and transferred the technology to CSL Behring in 2009. The key developers of Abstilla separated … View All Posts Post navigation Previous Post VerseWar – The First Ecosystem To Combine The Greatest Aspects Of Gaming And Digital …Next PostFTX opens cross-chain NFT trading between Ethereum and Solana, boosting SOL price rally